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populations to occupy southern
refugia [11] during colder periods,
e.g. during the cold isotope stage
4, 74–60 ky ago [17]. According to
this scenario, the northern regions
of the range, such as Germany and
Belgium, could have been
occupied by completely different
populations between 100 ky and
40 ky ago, if they originated from
different southern refugia.
Additional sampling of old and
recent Neandertal specimens
would be necessary to better
estimate the amount of genetic
diversity and population structure
prevailing 100 ky ago, and to
document changes in the
frequencies of different variants
over time. One would indeed want
to know if there has been
a replacement of genetic diversity
between 100 ky and 50 ky ago, or if
the diversity prevailing around
40–50 ky ago also existed 100 ky
ago. Such a task may seem
daunting, as the analysis of ancient
DNA is very tedious if one wants to
exclude contamination and post
mortem artefactual mutations [18].
It also seems particularly difficult
to validate ancient sequences that
are similar to those of modern
humans, as they could result from
contamination [6]. Therefore, if
analysis of Neandertals were to
reveal sequences similar to those
of modern humans, they would
certainly be considered as
contamination artefacts now.
While this may be of limited
concern in the case of
mitochondrial DNA, which has
a particularly high mutation rate,
this problem may become much
more important with possible
forthcoming Neandertal nuclear
sequences [19]. Nevertheless, with
the advent of additional
Neandertal mtDNA sequences, the
focus should now switch from the
mere relationship between
Neandertals and modern humans
to more Neandertal specific
questions, such as the dynamics
of their extension and retreat in
space and time.
References
1. Krings, M., Stone, A., Schmitz, R.W.,
Krainitzki, H., Stoneking, M., and
Paabo, S. (1997). Neandertal DNA
sequences and the origin of modern
humans. Cell 90, 19–30.
2. Ovchinnikov, I.V., Gotherstrom, A.,
Romanova, G.P., Kharitonov, V.M.,
Liden, K., and Goodwin, W. (2000).
Molecular analysis of Neanderthal DNA
from the northern Caucasus. Nature 404,
490–493.
3. Schmitz, R.W., Serre, D., Bonani, G.,
Feine, S., Hillgruber, F., Krainitzki, H.,
Paabo, S., and Smith, F.H. (2002). The
Neandertal type site revisited:
interdisciplinary investigations of skeletal
remains from the Neander Valley,
Germany. Proc. Natl. Acad. Sci. USA 99,
13342–13347.
4. Krings, M., Capelli, C., Tschentscher, F.,
Geisert, H., Meyer, S., von Haeseler, A.,
Grossschmidt, K., Possnert, G.,
Paunovic, M., and Paabo, S. (2000). A
view of Neandertal genetic diversity.
Nat. Genet. 26, 144–146.
5. Caramelli, D., Lalueza-Fox, C., Vernesi, C.,
Lari, M., Casoli, A., Mallegni, F.,
Chiarelli, B., Dupanloup, I.,
Bertranpetit, J., Barbujani, G., et al.
(2003). Evidence for a genetic
discontinuity between Neandertals and
24,000-year-old anatomically modern
Europeans. Proc. Natl. Acad. Sci. USA
100, 6593–6597.
6. Serre, D., Langaney, A., Chech, M.,
Teschler-Nicola, M., Paunovic, M.,
Mennecier, P., Hofreiter, M., Possnert, G.,
and Paabo, S. (2004). No evidence of
Neandertal mtDNA contribution to early
modern humans. PLoS Biol. 2, E57.
7. Currat, M., and Excoffier, L. (2004).
Modern humans did not admix with
Neanderthals during their range
expansion into Europe. PLoS Biol. 2,
2264–2274.
8. Hawks, J., and Wolpoff, M.H. (2001). Brief
communication: paleoanthropology and
the population genetics of ancient
genes. Am. J. Phys. Anthropol. 114,
269–272.
9. Nordborg, M. (1998). On the probability of
Neanderthal ancestry. Am. J. Hum. Genet.
63, 1237–1240.
10. Lalueza-Fox, C., Krause, J., Caramelli, D.,
Catalano, G., Milani, L., Sampietro, L.,
Calafell, F., Martı´nez-Maza, C., Bastir, M.,
Garcı´a-Tabernero, A., et al. (2006). The
mitochondrial hypervariable region I of an
Iberian Neandertal suggests a population
affinity with other European Neandertals.
Curr. Biol. 16, R629–R630.
11. Caramelli, D., Lalueza-Fox, C.,
Condemi, S., Longo, L., Milani, L.,
Manfredini, A., de Saint Pierre, M.,
Adoni, F., Lari, M., Giunti, P., et al. (2006).
A highly divergent mtDNA sequence in
a Neandertal individual from Italy. Curr.
Biol. 16, R630–R632.
12. Orlando, L., Darlu, P., Toussaint, M.,
Bonjean, D., Otte, M., and Hanni, C.
(2006). Revisiting Neandertal diversity
with a 100,000 year old mtDNA sequence.
Curr. Biol. 16, R400–R402.
13. Bazin, E., Glemin, S., and Galtier, N.
(2006). Population size does not influence
mitochondrial genetic diversity in animals.
Science 312, 570–572.
14. Pupko, T., and Galtier, N. (2002). A
covarion-based method for detecting
molecular adaptation: application to the
evolution of primate mitochondrial
genomes. Proc. Biol. Sci. 269, 1313–1316.
15. Excoffier, L., and Schneider, S. (1999).
Why hunter-gatherer populations do not
show sign of Pleistocene demographic
expansions. Proc. Natl. Acad. Sci. USA 96,
10597–10602.
16. Mellars, P. (2004). Neanderthals and the
modern human colonization of Europe.
Nature 432, 461–465.
17. Ambrose, S.H. (1998). Late Pleistocene
human population bottlenecks, volcanic
winter, and differentiation of modern
humans. J. Hum. Evol. 34, 623–651.
18. Willerslev, E., and Cooper, A. (2005).
Ancient DNA. Proc. Biol. Sci. 272, 3–16.
19. Dalton, R. (2006). Neanderthal DNA yields
to genome foray. Nature 441, 260–261.
20. Excoffier, L., and Yang, Z. (1999).
Substitution rate variation among sites in
the mitochondrial hypervariable region I of
humans and chimpanzees. Mol. Biol. Evol.
16, 1357–1368.
Computational and Molecular
Population Genetics Lab, Zoological
Institute, University of Berne,
Baltzerstrasse 6, 3012 Berne,
Switzerland.
E-mail: laurent.excoffier@zoo.unibe.ch
DOI: 10.1016/j.cub.2006.07.035
Current Biology Vol 16 No 16
R652Aging: Progeria and the Lamin
Connection
The relationship between progerias—diseases that resemble premature
aging—and the normal aging process has been a source of debate in the
aging research community. A recent study finds that LMNA, a gene
targeted for mutation in Hutchinson Gilford Progeria Syndrome, may
control the onset of aging-associated decline in normal fibroblasts.Brian A. Kudlow1,2
and Brian K. Kennedy1
Gerontologists have long been
intrigued by the amazing fidelity
with which some pathological
conditions, termed progerias,
resemble accelerated ‘normal’
human aging [1]. Despite obvious
similarities, none of the progeroidsyndromes replicate all
phenotypes associated with
aging, and it remains to be
determined whether the
determinants of ‘accelerated
aging’ and ‘normal aging’ overlap.
Recent work by Scaffidi and
Misteli [2], however, provides
evidence that the gene mutated in
Hutchinson-Gilford Progeria
Dispatch
R653Syndrome (HGPS), LMNA, may
have a role to play in facilitating
cellular senescence and, perhaps,
organismal aging.
Aging in humans and model
organisms is accompanied by
a number of characteristic
changes at the subcellular,
cellular, tissue and organismal
level. Among these is a reduction
in the proliferative capacity of cells
leading to a senescent phenotype
[3]. As a consequence and
although controversial, the study
of cell senescence is commonly
used as a proxy to understand
events associated with normal
aging. Underlying the exhaustion
of a cell’s replicative capacity is
a progressive shortening of
telomeres, although there are
a number of other cellular changes
that also contribute to the decline.
Among the myriad subcellular
changes that accompany aging
and senescence are changes to
nuclear organization, including
irregular nuclear morphology
and/or changes in patterns of
heterochromatin organization
[2,4]. The onset of these nuclear
changes is often accelerated in
pathological states associated
with changes in genes that are
linked to premature aging [5,6]. For
example, cells derived from
Werner Syndrome patients show
enhanced changes in nuclear
deformation and premature
senescence [1,7].
HGPS is perhaps the most
severe of the progeroid
syndromes, with affected
individuals having a mean life span
of about 13 years. HGPS is caused
by mutations in LMNA, the gene
encoding the A-type nuclear
lamins, primarily lamin A and C
[8,9]. Of note, over ten other
diseases, collectively termed
laminopathies have been linked to
missense mutations of LMNA
[10,11]. Although other LMNA
mutations have been associated
with HGPS, the most frequently
occurring mutation is a single
nucleotide change that results in
activation of a cryptic splice site
inside exon 11 and the subsequent
loss of 50 amino acids within the
carboxyl terminus of the encoded
protein [8,9]. The truncated protein,
termed D50 lamin A or progerin,
retains a carboxy-terminal farnesyl∆50 lamin A
level: HIGH Low Low
HGPS Normal Aging
Morpholino reduction
of ∆50 lamin A
Morpholino reduction
of ∆50 lamin A
Lamin A Heterochromatin markers DNA damage
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Figure 1. A model for the role of D50 lamin A in progeria and normal aging.
Cells either with normal LMNA genes or carrying a copy of the HGPS allele of LMNA start
out with low levels of D50 lamin A. The nuclear morphology is generally regular and het-
erochromatin is distributed throughout the nucleus. During normal aging, lamin A protein
redistributes away from the sites in the nuclear interior. This is associated with a decline
in the nuclear morphology and increased evidence of DNA damage. In HGPS cells, the
process is highly accelerated, probably because D50 lamin A levels accumulate to
much higher levels than in normal cells. Treating either aged fibroblasts or HGPS fibro-
blasts with a morpholino targeted to D50 lamin A reverses some of these defects.group, which is normally rapidly
cleaved off the wild-type lamin A
protein. A large body of evidence
suggests that LMNA mutations
leading to progeria are dominant,
gain-of-function alleles [11]. For
example, deletion of Lmna in the
mouse leads to muscular
dsyrtophy, whereas expression of
D50 lamin A leads to progeroid
phenotypes [12,13].
Scaffidi and Misteli [2] found that
cells from HGPS patients
prematurely display several
features in common with cells from
aged donors [2]. This includes
nuclear deformation, relocalization
of heterochromatin as visualized
by staining for tri-methyl-K9
histone H3 and HP1, as well as an
upregulated DNA damage
response. Some of these findings
were expected, as nuclear
deformation and alterations in
large-scale heterochromatin
organization are often associated
with mutations in LMNA [11]. Of
note, altering lamin function in
Caenorhabditis elegans adults
was found to cause both
premature mortality and severe
nuclear structural abnormalities
[14]. Finally, Scaffidi and Misteli [2]
report an age-dependent
redistribution of A-type lamins
from the nuclear interior to the
nuclear periphery, consistent withfindings that lamins are
concentrated at the periphery in
HGPS fibroblasts [15].
The surprising finding of Scaffidi
and Misteli [2] is that all human cell
lines and tissues observed,
despite having normal LMNA
genes, express a small amount of
D50 lamin A. Their findings show
that the normal LMNA gene, albeit
with considerably lower efficiency,
can be spliced in the same way as
the HGPS allele of LMNA, thus
producing the same D50 lamin A
protein. Importantly, they found
that treating fibroblasts from old
donors with morpholinos designed
to specifically reduce expression
of D50 lamin A led to a reversal of
the age-associated nuclear
phenotypes. This result suggests
that some nuclear changes
accompanying aging require
the presence of some threshold
level of D50 lamin A, which is
present in high levels in HGPS
cells (Figure 1).
When the authors [2] compared
cells from young and old donors,
or cells passaged in culture over
time, they were surprised to find
that the levels of D50 lamin A did
not increase with age. In contrast,
it is known that in cells from HGPS
patients, the abundance of D50
lamin A increases markedly with
passage number, and this
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R654accumulation is correlated with
a decline in nuclear organization
[15]. Scaffidi and Misteli [2]
propose that, in cells with normal
LMNA genes, it is the prolonged
exposure to low levels of D50
lamin A that leads to its deleterious
effects in aged cells. Another, non-
exclusive possibility is that other,
unknown changes that lead to the
nuclear alterations occur with age,
but that the deleterious effects of
these changes are enabled by the
presence of D50 lamin A. In this
view, the alternative splice product
is not the primary determinant of
age-related decline, but is required
for the decline to occur. In HGPS
patients, it may be that the
dramatically elevated levels ofD50
lamin A sensitize cells to the
changes that occur with normal
aging, leading to a more rapid
decline in proliferative potential
and premature senescence.
As with many novel findings, this
study [2] raises several questions
and directions of future research.
For instance, will prolonged
exposure to the splice-specific
morpholino delay the onset of
cellular senescence in normal
fibroblasts? What are the
functional differences in D50 lamin
A compared to normal lamin A that
promote the onset of nuclear aging
phenotypes? Finally, ifD50 lamin A
expression is conserved in the
mouse, can life span extension be
achieved by reducing the
expression of this Lmna splicevariant in vivo? While the study by
Scaffidi and Misteli [2] does not
unambiguously establish
mechanistic overlap between
progeria and normal aging, it
succeeds in establishing a line of
experimentally tractable questions
whose answers could resolve the
debate.
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